{
  "id": "NCLEXRN_NGN_SA_001",
  "itemType": "standalone",
  "questionType": "priorityAction",
  "question": {
    "stem": "The nurse is caring for a client in the emergency department. After reviewing the available data, which action is the highest priority for the nurse to take immediately?",
    "tabs": [
      {
        "id": "tab1",
        "label": "Nurses' Notes",
        "content": [
          {
            "timestamp": "0800",
            "note": "A 58-year-old male presents to the ED with his daughter, who is translating from Spanish. Daughter reports the client took a 'new blood pressure pill for the first time' this morning and developed sudden facial swelling, dizziness, and a 'rash on his chest' about 30 minutes ago. Client's home medication list is unavailable. Daughter denies any known allergies but states he 'had a reaction to a bee sting once'. Client appears anxious and is having difficulty speaking in full sentences."
          },
          {
            "timestamp": "0815",
            "note": "Client is becoming increasingly agitated, pointing to his throat. Audible, high-pitched inspiratory stridor is present. Skin is flushed with diffuse urticaria across the chest and abdomen. Oxygen applied via non-rebreather mask at 15 L/min. A 20-gauge IV has been established in the right antecubital fossa. Provider is at the bedside."
          }
        ]
      },
      {
        "id": "tab2",
        "label": "Vital Signs",
        "content": {
          "type": "table",
          "headers": [
            "Time",
            "Heart Rate (bpm)",
            "Blood Pressure",
            "Respiratory Rate (breaths/min)",
            "SpO2 (%)"
          ],
          "rows": [
            [
              "0805 (Triage)",
              "110",
              "118/76",
              "24",
              "94% on RA"
            ],
            [
              "0815",
              "135",
              "88/50",
              "32",
              "89% on 15L NRB"
            ]
          ]
        }
      },
      {
        "id": "tab3",
        "label": "Laboratory Results",
        "content": {
          "type": "table",
          "headers": [
            "Test",
            "Result",
            "Reference Range"
          ],
          "rows": [
            [
              "Lactate, Point-of-Care",
              "4.8 mmol/L",
              "< 2.0 mmol/L"
            ],
            [
              "Creatinine, Point-of-Care",
              "1.5 mg/dL",
              "0.7 - 1.3 mg/dL"
            ],
            [
              "Potassium, Point-of-Care",
              "4.1 mEq/L",
              "3.5 - 5.0 mEq/L"
            ]
          ]
        }
      },
      {
        "id": "tab4",
        "label": "Provider Orders",
        "content": {
          "timestamp": "0817",
          "orders": [
            "Epinephrine 0.5 mg, Intramuscular, STAT",
            "Diphenhydramine 50 mg, IV Push, STAT",
            "Methylprednisolone 125 mg, IV Push, STAT",
            "Normal Saline 1,000 mL, IV Bolus, Infuse over 30 minutes",
            "Labetalol 10 mg, IV Push, STAT, for HR > 120/min"
          ]
        }
      }
    ],
    "options": [
      {
        "id": "opt1",
        "label": "A",
        "content": "Administer Epinephrine 0.5 mg IM STAT."
      },
      {
        "id": "opt2",
        "label": "B",
        "content": "Administer Labetalol 10 mg IV push STAT."
      },
      {
        "id": "opt3",
        "label": "C",
        "content": "Administer Normal Saline 1,000 mL IV bolus."
      },
      {
        "id": "opt4",
        "label": "D",
        "content": "Administer Diphenhydramine 50 mg IV push STAT."
      }
    ]
  },
  "correctAnswer": [
    "opt1"
  ],
  "rationale": {
    "correct": "The client is exhibiting classic signs of anaphylactic shock, a life-threatening systemic allergic reaction. Key findings include acute airway compromise (inspiratory stridor), profound hypotension (BP 88/50 mmHg), compensatory tachycardia (HR 135 bpm), and signs of end-organ hypoperfusion (Lactate 4.8 mmol/L, Creatinine 1.5 mg/dL). Epinephrine is the first-line, life-saving intervention. Its alpha-1 adrenergic agonist effects cause vasoconstriction, reversing peripheral vasodilation and decreasing edema. Its beta-2 adrenergic agonist effects cause bronchodilation, reversing the life-threatening airway obstruction. Its beta-1 adrenergic effects increase heart rate and contractility, improving cardiac output. The increased lactate indicates anaerobic metabolism due to hypoperfusion. Elevated creatinine suggests acute kidney injury secondary to decreased renal perfusion. All other actions are secondary or contraindicated at this critical moment.",
    "incorrect": "The incorrect options represent either a failure to prioritize the most critical intervention or a life-threatening medication error. This scenario requires the nurse to recognize a state of profound distributive shock and airway compromise and select the only medication that reverses the underlying pathophysiology. Choosing any other option first delays life-saving treatment or actively causes harm.",
    "answerBreakdown": [
      {
        "label": "A",
        "content": "Administer Epinephrine 0.5 mg IM STAT.",
        "isCorrect": true,
        "justification": "This is the correct priority action. Epinephrine directly counteracts the life-threatening manifestations of anaphylaxis: it relieves airway obstruction from laryngeal edema and bronchospasm and reverses the profound vasodilation causing hypotension and shock. The clinical data (stridor, SpO2 89%, BP 88/50 mmHg) mandate its immediate administration. The IM route is preferred initially for rapid absorption in this emergent situation."
      },
      {
        "label": "B",
        "content": "Administer Labetalol 10 mg IV push STAT.",
        "isCorrect": false,
        "justification": "This action is extremely dangerous and represents a critical safety error. The client's tachycardia (HR 135 bpm) is a vital compensatory response to profound hypotension (BP 88/50 mmHg). Administering a beta-blocker like Labetalol would block this response, leading to a catastrophic drop in cardiac output and likely causing cardiovascular collapse and cardiac arrest. Labetalol is contraindicated in hypotensive shock. The medication would further reduce blood pressure by blocking compensatory adrenergic responses."
      },
      {
        "label": "C",
        "content": "Administer Normal Saline 1,000 mL IV bolus.",
        "isCorrect": false,
        "justification": "While aggressive fluid resuscitation is a necessary component of treating anaphylactic shock, it is not the first priority. The primary problem is massive vasodilation and capillary leakage. Without first administering epinephrine to constrict blood vessels, the IV fluid will not effectively raise blood pressure and will continue to leak into the interstitial space, potentially worsening edema. Epinephrine must be given first to 'tighten the pipes' before fluid administration can be effective. Fluid resuscitation follows epinephrine administration."
      },
      {
        "label": "D",
        "content": "Administer Diphenhydramine 50 mg IV push STAT.",
        "isCorrect": false,
        "justification": "Diphenhydramine is an H1-antagonist and is considered a second-line treatment. It can help manage cutaneous symptoms like urticaria but does not effectively reverse life-threatening airway obstruction or hypotension. Prioritizing diphenhydramine over epinephrine delays definitive, life-saving treatment for shock and airway compromise. Diphenhydramine addresses histamine-mediated symptoms but does not directly address the vasodilation and bronchoconstriction."
      }
    ]
  },
  "pedagogy": {
    "bloomLevel": "Analyzing",
    "cjmmStep": "Take Actions",
    "nclexCategory": "Physiological Adaptation",
    "difficulty": "4",
    "topicTags": [
      "Anaphylaxis",
      "Shock",
      "Medication Safety",
      "Contraindication",
      "Prioritization",
      "Emergency Nursing",
      "Health Equity"
    ]
  },
  "scenario": {
    "sbar": {
      "situation": "At 0815, a 58-year-old male presents to the emergency department with sudden facial swelling, dizziness, and a rash on his chest after taking a new blood pressure pill this morning.",
      "background": "The client's daughter, translating from Spanish, reports the medication was taken this morning. The client's home medication list is unavailable. The daughter denies known allergies but mentions a past reaction to a bee sting. The client is anxious and has difficulty speaking in full sentences.",
      "assessment": "The client is increasingly agitated, pointing to his throat. Audible inspiratory stridor is present. Skin is flushed with diffuse urticaria across the chest and abdomen. Vital signs: HR 135 bpm, BP 88/50 mmHg, RR 32 breaths/min, SpO2 89% on 15L NRB. Lactate is 4.8 mmol/L, and Creatinine is 1.5 mg/dL.",
      "recommendation": "The priority action is to administer epinephrine 0.5 mg IM STAT due to the client's signs and symptoms of anaphylactic shock, including airway compromise and hypotension."
    }
  },
  "clinicalPearl": "In anaphylactic shock, always prioritize interventions that address airway, breathing, and circulation (ABC). Epinephrine is the first-line medication to reverse the life-threatening effects of anaphylaxis by promoting bronchodilation and vasoconstriction. Be cautious when administering medications that can further compromise blood pressure in hypotensive patients; beta-blockers are generally contraindicated. Remember that elevated lactate and creatinine can indicate hypoperfusion and acute kidney injury, respectively.",
  "sentinelStatus": "healed_v2026_v8"
}